InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 01/22/2019 7:06:30 AM

Tuesday, January 22, 2019 7:06:30 AM

Post# of 225
News: $CGEN Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for Cancer Immunotherapy

HOLON, Israel , Jan. 22, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced the online publication of preclinical data demonstrating the role of PVRIG as a novel immune checkpoint an...

In case you are interested https://marketwirenews.com/news-releases/compugen-announces-publication-of-two-peer-reviewed-papers-demonstrating-the-role-of-pvrig-as-a-novel-immune-checkpoint-for-cancer-immunotherapy-7412678.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGEN News